PLGO · NYSE · Insurance - Diversified

Pelagos Insurance Capital (PLGO)

Specialty insurer and reinsurer built around delegated underwriting partnerships.

$23.88
vs last close+0.32 (+1.36%)
Loading prices…

Pelagos Insurance Capital LimitPLGO
Financial sector

Writes specialty insurance and property-catastrophe reinsurance, earning premiums and investment income on insurance float. A capital-allocation model separates regulated risk carriers from much of the delegated underwriting and claims work performed by The Fidelis Partnership.

Operates regulated insurance carriers in Bermuda, the United Kingdom and Ireland, writing specialty insurance and property-catastrophe reinsurance. Product lines include commercial property, marine, energy, aviation and aerospace, cyber, structured credit, political risk, violence and terror, plus quota-share, excess-of-loss and retrocession cover.

Earns premiums for assuming risk and investment income on insurance float, while setting underwriting strategy and allocating capital. The Fidelis Partnership performs most origination, underwriting, claims handling and reinsurance administration under a rolling agreement; Pelagos retains risk appetite, oversight and approval over large claims. Brokers and reinsurance intermediaries distribute global risk business, while regulated subsidiaries must maintain capital and the parent depends on their distributions for liquidity.

Company facts

CEODaniel Burrows
ListedJun 29, 2023
ExchangeNYSE
HeadquartersPembroke, Bermuda
CountryBermuda
Employees108
CIK0001636639
ISINBMG3398L1182

Market cap$2.01B
EPS (ttm)$4.08
P/E (ttm)5.77
ROE17.3%
P/B0.9071
P/S0.9318
Dividend yieldDiv yield2.55%
Beta

Price target$23.50−0.3%Average of 7 analysts
ConsensusBuy3 of 7 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 13, 2026BarclaysReiterate
Rating: Target: $24
Rating: Equal WeightTarget: $23
Jul 10, 2026Evercore ISITarget
Target:
Target: $24
Jul 8, 2026UBSReiterate
Rating: Target:
Rating: BuyTarget: $29
Jul 7, 2026BarclaysTarget
Target: $22
Target: $24
Jul 1, 2026Goldman SachsReiterate
Rating: Target:
Rating: SellTarget: $22.50

Next report
Nov 11, 26
in 49 days
EPS estimate
$0.69
Revenue estimate
$703.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$1.05−$0.41$0.12$1.21$1.09$0.94$0.34Pending
Estimate−$0.73−$0.47−$0.39$1.19$1.06$0.75$0.88$0.69
Surprise−44.5%+12.1%+131.0%+1.7%+2.8%+25.3%−61.3%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$953.7M$658.4M$1.22B$797.5M$978.2M$1.84B$1.30BPending
Estimate$638.7M$685.1M$637.4M$638.6M$725.3M$903.2M$787.0M$703.0M
Surprise+49.3%−3.9%+91.3%+24.9%+34.9%+103.8%+64.8%
Estimate$0.69
ReportedDue Nov 11, 2026
Estimate$703.0M
ReportedDue Nov 11, 2026
View details

Debt to equity32.40%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$680.7M$680.3M$577.5M$591.3M$650.2M$274.8M$612.3M$624.4M
Net income$100.6M−$122.2M−$42.5M$19.7M$130.5M$117.8M$108.0M$44.4M
Net margin14.8%0.0%0.0%3.3%20.1%42.9%17.6%7.1%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$117.9M−$139.5M−$50.3M$22.2M$160.8M$142.9M$103.1M$52.9M
YoY growthTurned lossTurned loss−64.7%+36.4%Turned profitTurned profit+138.3%

Balance sheet, Jun 30, 2026Cash & short-term investments $517.1M · Total debt $720.5M · Total assets $10.76B · Shareholders' equity $2.22B

Revenue
$624.4M
Operating income
$52.9M
Net income
$44.4M
View details

Dividend yield
2.55%
Next ex-date
Dec 14, 26
estimated · in 82 days
Annual dividend
$0.60
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Dividend$0.10$0.10$0.10$0.15$0.15$0.15$0.15$0.15
Annual yield2.59%2.41%
Ex-dateNov 29Mar 12Jun 16Sep 16Dec 10Mar 16Jun 15Sep 14
Payment dateDec 20Mar 27Jun 27Sep 26Dec 23Mar 27Jun 26Sep 25
View details

No ownership filings on record for this listing.

  • AXIS Capital

    Broad global specialty and reinsurance capacity across core lines.

  • Everest Group

    Scaled global insurance and reinsurance capacity across property and specialty.

  • Hamilton Insurance Group

    Bermuda and Lloyd's specialist across insurance and reinsurance.

  • Lead Real Estate (ADR)

    Short-tail specialist in property, marine, energy, aviation and reinsurance.

  • Markel Group

    Large specialty-insurance rival in property, marine, energy and credit.

  • Cre8 Enterprise

    Bermuda treaty reinsurer for property catastrophe and specialty capacity.

Compare

CompanyPriceChange
Pelagos Insurance Capital$23.88+1.36%$2.01B5.86.30.9+6.4%
AXIS Capital$96.57+0.30%$7.03B6.17.41.0+7.4%
Everest Group$375.29+1.17%$14.68B7.96.80.9−10.1%
Hamilton Insurance Group$33.81+0.21%$3.37B5.97.71.1+16.7%
Lead Real Estate (ADR)$1.08+1.89%$14.5M2.40.1
Markel Group$1,763.84+0.03%$21.85B9.715.41.3+17.6%
Cre8 Enterprise$2.94−0.51%$5.9M
Median6.17.51.0+12.0%